The Volume of Three-Dimensional Cultures of Cancer Cells InVitro Influences Transcriptional Profile Differences and Similarities with Monolayer Cultures and Xenografted Tumors
暂无分享,去创建一个
Catarina Brito | Xin Lu | Kedar S Vaidya | Xin Lu | T. Uziel | M. Mitten | C. Brito | E. Boghaert | Anatol Oleksijew | V. E. Santo | Tamar Uziel | T. Mcgonigal | Erwin R. Boghaert | Michael J. Mitten | Paul E. Hessler | Thomas P. McGonigal | Kelly Foster-Duke | Jonathan A. Hickson | Vitor E. Santo | Kedar S. Vaidya | J. Hickson | P. Hessler | Anatol Oleksijew | Kelly D. Foster-Duke
[1] L. Kunz-Schughart,et al. Multicellular tumor spheroids: an underestimated tool is catching up again. , 2010, Journal of biotechnology.
[2] K. Wittrup,et al. Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids , 2008, Molecular Cancer Therapeutics.
[3] Christilyn P. Graff,et al. Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention. , 2003, Cancer research.
[4] V. Virador,et al. In vitro three‐dimensional (3D) models in cancer research: An update , 2013, Molecular carcinogenesis.
[5] A. Atala,et al. Scaffold technologies for controlling cell behavior in tissue engineering. , 2013, Biomedical materials.
[6] Rebecca L. Siegel Mph,et al. Cancer statistics, 2016 , 2016 .
[7] Alan Ruttenberg,et al. Computational knowledge integration in biopharmaceutical research , 2003, Briefings Bioinform..
[8] Hans Clevers,et al. Organoid cultures for the analysis of cancer phenotypes. , 2014, Current opinion in genetics & development.
[9] P. Workman,et al. Discovery of small molecule cancer drugs: Successes, challenges and opportunities , 2012, Molecular oncology.
[10] W. Mueller‐Klieser. Three-dimensional cell cultures: from molecular mechanisms to clinical applications. , 1997, American journal of physiology. Cell physiology.
[11] D. Quail,et al. Microenvironmental regulation of tumor progression and metastasis , 2014 .
[12] V. Lemmens,et al. Does long-term survival exist in pancreatic adenocarcinoma? , 2016, Acta oncologica.
[13] A. Mes-Masson,et al. Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines , 2008, BMC Medical Genomics.
[14] R. Sutherland. Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.
[15] Sami Blom,et al. Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery , 2016, Scientific Reports.
[16] Alexander Kamb,et al. What's wrong with our cancer models? , 2005, Nature Reviews Drug Discovery.
[17] A. Zauber,et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. , 2012, The New England journal of medicine.
[18] A. Maxmen. Translational research: The American way , 2011, Nature.
[19] R. Herbst,et al. Lung Cancer in the Era of Precision Medicine , 2015, Clinical Cancer Research.
[20] J. Yuhas,et al. A simplified method for production and growth of multicellular tumor spheroids. , 1977, Cancer research.
[21] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Ghert,et al. Lost in translation: animal models and clinical trials in cancer treatment. , 2014, American journal of translational research.
[23] Nastaran Zahir,et al. Death in the third dimension: apoptosis regulation and tissue architecture. , 2004, Current opinion in genetics & development.
[24] Mina J Bissell,et al. The organizing principle: microenvironmental influences in the normal and malignant breast. , 2002, Differentiation; research in biological diversity.
[25] J. Salk. Clonal evolution in cancer , 2010 .
[26] Giulio Draetta,et al. Oncology drug discovery: planning a turnaround. , 2014, Cancer discovery.
[27] Matthias Gutekunst,et al. Three‐dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivo , 2014, Biotechnology journal.
[28] Simon T Barry,et al. Modelling the tumour microenvironment in long-term microencapsulated 3D co-cultures recapitulates phenotypic features of disease progression. , 2016, Biomaterials.
[29] Robert V Farese,et al. Cellular fatty acid metabolism and cancer. , 2013, Cell metabolism.
[30] C. Ries,et al. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab , 2009, Oncogene.
[31] I. Tannock,et al. Drug penetration in solid tumours , 2006, Nature Reviews Cancer.
[32] A. Mikos,et al. Modeling Ewing sarcoma tumors in vitro with 3D scaffolds , 2013, Proceedings of the National Academy of Sciences.
[33] John D. Storey,et al. A network-based analysis of systemic inflammation in humans , 2005, Nature.
[34] Darren Finlay,et al. 3-Dimensional Culture Systems for Anti-Cancer Compound Profiling and High-Throughput Screening Reveal Increases in EGFR Inhibitor-Mediated Cytotoxicity Compared to Monolayer Culture Systems , 2014, PloS one.
[35] I. Fidler,et al. Murine models to evaluate novel and conventional therapeutic strategies for cancer. , 2007, The American journal of pathology.
[36] W. Bodmer,et al. Cancer cell lines for drug discovery and development. , 2014, Cancer research.
[37] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[38] A. Balmain,et al. Guidelines for the welfare and use of animals in cancer research , 2010, British Journal of Cancer.
[39] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[40] S. Barry,et al. Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices , 2015, Scientific Reports.
[41] Catarina Brito,et al. Adaptable stirred-tank culture strategies for large scale production of multicellular spheroid-based tumor cell models. , 2016, Journal of biotechnology.